Italian regulator fines Google €100 million for abusing market position
Category: #business  By Nikita Chaurasia  Date: 2021-05-14
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Italian regulator fines Google €100 million for abusing market position

Google is facing a USD 123 million fine from the Italian competition regulator for misusing its market position. The case is specifically related to Google’s in-car operating system, Android Auto.

According to reliable sources, Google had restricted access to Juicepass, an electric car charging app developed by Enel X Italia. The American tech giant is accused of giving preference to its real-time navigation app, Google Maps.

Meanwhile, Google has courteously disagreed with Italy’s accusations. The company claims to have always prioritized user safety while driving and has therefore set a strict set of guidelines for the applications on Android Auto.

It appears that Google has been working on opening Android Auto to more third-party apps, with additional plans to expand its availability across the globe. However, it is still unclear why Google did not provide access to JuicePass for the past couple of years.

For a while, both French and the European authorities have been closely monitoring and strictly surveying the U.S.-based tech giants namely Google, Facebook, Apple, and Amazon for paying relatively low taxes.

Google had previously settled a four-year-old French financial fraud lawsuit for USD 1.2 billion in September last year. The search engine giant was also penalized around USD 181 million by the French authorities for its ambiguous advertising on the Google Ads page resulting in anticompetitive behavior.

According to the competition regulator, Google has maintained a dominant position in the Android smartphone space for a while, capturing approximately three-quarters share in Italy alone.

The European Union law states that any company that holds a dominant position in a specific market should not restrict competition in any other markets. Back in 2017, the EU had already identified Google as a dominant entity in online search across every market in the European Economic Area.

Meanwhile, a U.S. judge has reportedly dismissed antitrust claims against Google which were brought up by various advertisers, asking them to provide a better explanation why the company’s refusal to support rival systems is termed as anticompetitive.

Source Credits-

https://tech.hindustantimes.com/tech/news/Google-fined-102-million-euros-by-italy-s-antitrust-for-abuse-of-dominant-position-71620890486396.html

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Coretec Group, Eindhoven University join hands for research works

Coretec Group, Eindhoven University join hands for research works

By Nikita Chaurasia

U.S.-based new silicon products pioneer Coretec Group Inc. has reportedly entered into a research partnership with Eindhoven University of Technology (TU/e), which is among the leading 50 universities in engineering and technology globally as per QS ...

FedEx partners with Nuro to develop autonomous package delivery systems

FedEx partners with Nuro to develop autonomous package delivery systems

By Nikita Chaurasia

FedEx Corporation and robotics startup Nuro have reportedly signed a multi-year agreement to develop and test last-mile delivery using autonomous vehicles. The American multinational delivery giant will be using its Houston facility for the pilot pro...

Breckenridge Pharmaceutical receives FDA approval for anti-cancer drug

Breckenridge Pharmaceutical receives FDA approval for anti-cancer drug

By Nikita Chaurasia

According to reliable sources, Natco Pharma’s marketing partner Breckenridge Pharmaceutical Inc. has obtained approval from U.S. Food and Drug Administration (USFDA), for its anti-cancer drug Carfilzomib Vials. For the record, Carfilzomib Vial...